GlassScriptPhysician profile
Xuemei Yao
NPI 1235674193
$2,434.09
in general payments reported to CMS, 2019-2025
16 companies · $516 in 2025
The $516 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.72 · 2022: $138 · 2023: $1,064 · 2024: $676 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $468.68 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.64 | 2023-2025 | Jardiance |
| Abiomed | $295.93 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.51 | 2023-2025 | Lifevest |
| Pfizer INC. | $187.34 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $169.23 | 2021-2024 | Farxiga |
| Lantheus Medical Imaging, INC. | $141.88 | 2023 | Definity |
| Merck Sharp & Dohme LLC | $116.73 | 2024 | Winrevair |
| Edwards Lifesciences Corporation | $106.27 | 2025 | |
| Shockwave Medical, INC | $103.48 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $86.20 | 2025 | Perclose Prostyle, Navitor |
| Abbvie INC. | $81.15 | 2023-2024 | |
| Bridgebio Pharma, INC. | $72.95 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $32.72 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $16.41 | 2025 | Assure Wcd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xuemei Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.